---
title: "Moderna 股票上漲 15%，多頭因藥物研發管線更新而歡呼：下一目標是 75 美元？"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/290996249.md"
description: "Moderna 的股價在其藥物研發的積極商業更新後上漲了近 15%，達到約 69 美元，包括在癌症和自身免疫治療方面的進展。過去一個月，該股上漲了約 42%，表現優於標準普爾 500 指數。技術指標顯示，如果突破 68 美元的阻力位，可能會向 75 美元上漲，支撐位在 63 美元。儘管股價上漲，分析師仍維持持有評級"
datetime: "2026-06-26T18:05:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290996249.md)
  - [en](https://longbridge.com/en/news/290996249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290996249.md)
---

# Moderna 股票上漲 15%，多頭因藥物研發管線更新而歡呼：下一目標是 75 美元？

Moderna (MRNA) shares surged nearly ~15% on Friday to around ~$69 and are now up almost ~42% over the past month. The stock has also crushed the S&P 500 (SP500)'s return of ~7.49%, delivering gains of more than ~114% over the same period. The Moderna stock rally came after the company shared a major business update on its Science Day event that gav...

### 相關股票

- [MRNA.US](https://longbridge.com/zh-HK/quote/MRNA.US.md)
- [MRNX.US](https://longbridge.com/zh-HK/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/zh-HK/quote/MRNY.US.md)
- [.SPX.US](https://longbridge.com/zh-HK/quote/.SPX.US.md)

## 相關資訊與研究

- [Moderna 公司將其體內 CAR-T 候選藥物 mRNA-6007 推進到針對自身免疫疾病的早期開發階段](https://longbridge.com/zh-HK/news/290822266.md)
- [這隻股票今年已經翻倍，並且仍在朝着一個重要的催化劑前進](https://longbridge.com/zh-HK/news/290916339.md)
- [屈臣氏 7 月再辦藥餘回收計劃 夥 20 社福機構 回收點擴至逾 75 個](https://longbridge.com/zh-HK/news/290683677.md)
- [萬寧連續 4 年推「回收藥物計劃」藥劑師可免費提供用藥諮詢](https://longbridge.com/zh-HK/news/290664183.md)
- [富邦證券輔導 TLC BioSciences Corp. 6 月 26 日登錄興櫃](https://longbridge.com/zh-HK/news/290776423.md)